AltheaDx Secures $6,000,000 Series A Funding Round

  • Feed Type
  • Date
    4/13/2010
  • Company Name
    AltheaDx
  • Mailing Address
    3550 Dunhill Street San Diego, CA 92121
  • Company Description
    Our proprietary gene expression profiles include assays for differential diagnosis of pediatric cancers and for improved diagnosis and management of prostate cancer. We have a track record of reducing the time, risk, and cost of drug development by providing biomarker discovery and development to biopharma clients and clinical testing services to physicians.
  • Website
    http://www.altheadx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    This Series A capital will support our existing biopharma partnerships that are focused on the development of biomarkers and companion diagnostics which will be instrumental in bringing safer therapeutics to patients.
  • M&A Terms
  • Venture Investor
    Telegraph Hill Partners
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.